T3 Pharma, a spin-off of the University of Basel and one of our portfolio, has raised over $12 million from Boehringer Ingelheim Venture Fund and…
Jérémie Meyer02.03.2020
T3 Pharmaceuticals is among the winners of this year’s W.A. de Vigier Award. The spin-off from the University of Basel is developing a targeted cancer…
Jérémie Meyer28.05.2019
Leading venture capital firm Sofinnova Partners led the Series A financing, together with New Enterprise Associates, which co-led the round Basel, Switzerland, 28 March 2019–Polyneuron…
Jérémie Meyer28.03.2019
Onur Boyman, an immunologist working at the University Hospital Zurich and UZH, has joined forces with Andreas Katopodis to establish Anaveon, a BaseLaunch participant. Aiming to translate…
Jérémie Meyer20.06.2018
Polyneuron Pharmaceuticals, a BaseLaunch participant, has successfully raised over 3 million Swiss francs in a financing round. The Basel-based pharmaceutical company is developing an active…
Jérémie Meyer14.05.2018
Biotech is a lot like venture capital. Vast amounts of research, testing and marketing go into a wide range of therapies. But in the end,…
Jérémie Meyer10.03.2018
